Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1995 | 09-1995 | 06-1995 | 03-1995 | 12-1994 | |
| Sales | 299,220 | 283,094 | 227,335 | 215,665 | 121,606 |
| Cost of Goods | 119,818 | 65,560 | 66,191 | 64,412 | 43,583 |
| Gross Profit | 311,101 | 167,202 | 161,144 | 151,253 | 78,023 |
| Operating Expenses | 148,551 | 93,295 | 91,400 | 116,676 | 40,830 |
| Operating Income | 31,669 | 124,799 | 69,935 | 34,989 | 37,776 |
| Interest Expense | 1,979 | 1,239 | 2,901 | 2,053 | 599 |
| Other Income | -36,697 | -50,290 | 4,941 | -85,401 | 859 |
| Pre-tax Income | -7,007 | 73,270 | 71,975 | -52,465 | 38,036 |
| Income Tax | 8,912 | 26,230 | 26,055 | 16,168 | 14,857 |
| Net Income Continuous | -27,489 | 49,356 | 45,920 | -68,633 | 23,179 |
| Net Income | $-27,489 | $49,356 | $45,920 | $-68,633 | $23,179 |
| EPS Basic Total Ops | -0.04 | 0.08 | 0.08 | -0.11 | 0.06 |
| EPS Basic Continuous Ops | -0.04 | 0.08 | 0.07 | -0.11 | 0.06 |
| EPS Diluted Total Ops | -0.04 | 0.07 | 0.08 | -0.11 | 0.06 |
| EPS Diluted Continuous Ops | -0.04 | 0.07 | 0.07 | -0.11 | 0.06 |
| EBITDA(a) | $31,669 | $124,799 | $69,935 | $34,989 | $37,776 |